MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$36,223K
Prepaid expenses and
other current assets
$2,249K
Research and development
incentives receivables
$1,562K
Property and equipment,
at cost
$1,069K
Total current assets
$40,034K
Intangible assets, net
$381K
Operating lease right of
use assets, net
$108K
Property and equipment,
net
$91K
Less accumulated
depreciation
$978K
Total assets
$40,614K
Total liabilities and
shareholders' equity
$40,614K
Total shareholders'
equity
$34,054K
Total liabilities
$6,560K
Accumulated deficit
-$507,538K
Accumulated other
comprehensive loss
-$12,571K
Additional paid-in capital
$551,018K
Total current
liabilities
$6,177K
Other non-current
liabilities
$362K
Warrant liabilities -
non-current
$21K
Ordinary shares, par
value 0.003 per share...
$3,145K
Accounts payable
$3,226K
Accrued expenses
$2,046K
Other current
liabilities
$905K
Back
Back
Balance Sheet
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)
source: myfinsight.com